Tuesday's top brokerage calls: Britannia, Aurobindo Pharma and Sun TV

SUMMARY

Citi has maintained its 'buy' recommendation on Aurobindo Pharma while JP Morgan believes price hikes and cost measures are in place to support Britannia Industries' profitability going ahead. Here are the top brokerage calls for the day:

By CNBCTV18.comNov 9, 2021 8:19:32 AM IST (Published)

Nomura on Britannia Industries | Key risks include slower/faster volume growth in biscuits, said Nomura, maintaining its 'neutral' call on the company's stock. The brokerage said demand is holding up well but margin, not so much.

Citi on Aurobindo Pharma | The brokerage that has maintained its 'buy' recommendation, would like to watch the company's guidance on margin outlook. Weakness in profitability is in-line with expectations, the brokerage added.

JP Morgan on Britannia | The brokerage believes price hikes and cost measures are in place to support profitability going ahead. JP Morgan has an 'overweight' rating on shares of Britannia.

Macquarie on Sun TV | Valuations are reasonable at current levels, said Macquarie that has retained its 'outperform' rating on shares of Sun TV. The brokerage pointed out that a key positive from Q2 results is a sharp recovery in advertising revenue.